Extended neonatal screening identifies important biomarkers for serious illnesses that directly endanger the health and possibly the life of the newborn.

We use:

a) LC / MSMS mass spectroscopy using the most appropriate system QTRAP 4000 of SCIEX and b) ELISA using the automated Autodelfia system, responding to 60 metabolic diseases.

You may also like

Recently Viewed